The present invention provides a therapeutic method for removing amyloid fibrils from a patient. The present invention also provides a transgenic animal that develops systemic AA amyloidosis within three weeks for use as a tool to investigate AA amyloidosis and to evaluate agents that may be potentially...http://www.google.de/patents/US7485616?utm_source=gb-gplus-sharePatent US7485616 - Methods of investigating, diagnosing, and treating amyloidosis
